PDS Biotechnology Corporation
PDSB
$0.29
-$0.01-2.33%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 8.01% | 6.03% | 8.28% | 13.98% | 10.02% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 1.17% | 2.37% | 3.60% |
| Total Amortization of Deferred Charges | -55.69% | 49.23% | 34.31% | 23.05% | 104.58% |
| Total Other Non-Cash Items | 60.48% | -24.94% | -22.53% | -23.32% | -29.64% |
| Change in Net Operating Assets | 243.82% | 148.04% | 93.34% | -40.93% | -118.53% |
| Cash from Operations | 51.17% | 32.33% | 20.78% | 8.42% | 0.18% |
| Capital Expenditure | -- | -- | -- | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 100.00% | 100.00% |
| Total Debt Issued | -83.11% | -- | -- | -- | -- |
| Total Debt Repaid | 10.97% | -282.13% | -708.85% | -49,345.60% | -48,581.46% |
| Issuance of Common Stock | -49.17% | -29.38% | -40.16% | -56.77% | -61.72% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 34.40% | 1.03% | -- | -- | -- |
| Cash from Financing | -211.60% | -36.34% | -36.72% | -71.64% | -73.05% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.61% | 31.28% | -0.72% | -423.37% | -794.42% |